Safety Study of HSK55879 Tablet in Healthy Adults
This early-stage study tests how a new experimental medication (HSK55879) is tolerated and processed by the body in healthy volunteers. Researchers will also check how food affects the drug's absorption to help determine safe dosing for future patient studies.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be between 18 and 45 years old and in generally good health
- Weigh at least 50 kg (110 lbs) if male or 45 kg (99 lbs) if female
- Have a healthy body mass index (BMI) between 19.0 and 28.0
- Have no significant medical conditions affecting the stomach, liver, kidneys, or heart
- Agree not to plan pregnancy and use reliable contraception for 3 months after the study ends
- Pass screening blood tests, urine drug test, and infectious disease screening (hepatitis, HIV, syphilis)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This is an early-stage safety study testing a new tablet called KHN707 in healthy volunteers. Researchers want to understand how the body processes the drug and check for any side effects.
This is an early-stage safety test of a new investigational drug called HSK56630 in healthy volunteers with no major medical conditions. Researchers will monitor how your body tolerates the drug and what side effects might occur.
This first-in-human trial tests a new medication called HSK47388 in healthy volunteers to see if it's safe and how the body processes it. If you're generally healthy, you may be able to help researchers understand this potential new treatment.
This is an early-stage safety study testing a new experimental tablet called SYH2072 in healthy volunteers. Researchers will give increasing doses to understand how safe it is, how your body processes it, and what effects it has.
This trial tests a new medicine called SPH9788 in healthy people to see how the body handles it. Volunteers must be generally healthy and follow lifestyle rules to help researchers understand the drug's safety and effects.
This trial tests a new tablet called KHN702 in healthy people to see how safe it is and how the body processes it. It helps researchers understand the right dose and any side effects before moving to larger studies.
Hear when a new Healhty trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.